Sterile Water Injection
Brand: STERILE WATER
This drug is currently listed as in shortage by the FDA. Affected manufacturer: Nephron Pharmaceuticals Corporation.
Active FDA Drug Shortage
Contact your pharmacist if you are affected. They can check availability from other manufacturers or suggest alternatives.
Shortage Details
- Generic Name
- Sterile Water Injection
- Manufacturer
- Nephron Pharmaceuticals Corporation
- Dosage Form
- Injection
- Presentation
- Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01)
- Package NDC
- 0487-6105-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availabiltiy
- First Reported
- Nov 23, 2021
- Last Updated
- Jan 7, 2026
- Therapeutic Category
- Other
Shortage Reason
Two lots available for commercial use. Expiration date 12/31/2026
Nearby — Other Sterile Shortage Records
Sterile Water Irrigant
B. Braun Medical Inc.
Irrigant
Sterile Water Irrigant
B. Braun Medical Inc.
Irrigant
Sterile Water Irrigant
Otsuka ICU Medical LLC
Irrigant
Sterile Water Irrigant
Otsuka ICU Medical LLC
Irrigant
Sterile Water Irrigant
Otsuka ICU Medical LLC
Irrigant
Sterile Water Irrigant
Otsuka ICU Medical LLC
Irrigant
Frequently Asked Questions
Why is Sterile in shortage?
What can I do if my medication is in shortage?
How often is this data updated?
What This Sterile Shortage Record Means
The FDA Drug Shortages database lists this record for Sterile Water Injection (brand: STERILE WATER) from Nephron Pharmaceuticals Corporation with a current status of Active Shortage. The affected dosage form is Injection, presented as Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01). Shortages are tracked at the manufacturer and presentation level — other manufacturers or formulations of the same generic may remain available, which is why pharmacists often can source a working substitute even when one record is flagged.
This shortage was first reported on Nov 23, 2021 and was last updated Jan 7, 2026. The FDA cites the following reason: Two lots available for commercial use. There are 6 other current records in this database covering the same generic, which gives a fuller picture of how disruption is playing out across manufacturers and dosage forms.
A shortage listing is a supply-side signal, not a patient-level instruction. Access can vary dramatically by pharmacy, region, hospital system, and insurance formulary — local pharmacists have real-time visibility that a national database cannot provide. Therapeutic substitutes often exist in the same class, but switching decisions belong with your prescriber, who weighs efficacy, dosing conversion, interaction profile, and personal history. This page summarizes public FDA data for educational reference only and is not medical advice. If your medication is affected, contact your pharmacist and prescriber to plan an appropriate response.
Disclaimer: This information comes from the FDA Drug Shortages Database and is for educational purposes only. It is not medical advice. Do not stop or change any medication without consulting your healthcare provider or pharmacist. Shortage status can change rapidly — always verify current availability with your pharmacist.
Read our methodology — how this data is sourced, computed, and verified.